adamantane has been researched along with sk&f-38393 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Britton, DR; DeNinno, MP; Jenner, P; Kebabian, JW; Perner, R; Schoenleber, R; Smith, L; Williams, M | 1 |
| Huang, NY; Kostrzewa, RM | 1 |
| Wirtshafter, D | 1 |
3 other study(ies) available for adamantane and sk&f-38393
| Article | Year |
|---|---|
A-77636: a potent and selective dopamine D1 receptor agonist with antiparkinsonian activity in marmosets.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adamantane; Administration, Oral; Animals; Antiparkinson Agents; Benzazepines; Benzopyrans; Binding Sites; Callithrix; Cell Line; Dopamine Agents; Fishes; Injections, Subcutaneous; Mice; Motor Activity; Oxidopamine; Parkinson Disease, Secondary; Rats; Receptors, Dopamine D1 | 1992 |
Enhanced oral activity response to A77636 in neonatal 6-hydroxydopamine-lesioned rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adamantane; Analysis of Variance; Animals; Animals, Newborn; Behavior, Animal; Benzopyrans; Dopamine Agents; Female; Injections, Intraperitoneal; Injections, Intraventricular; Male; Mouth; Oxidopamine; Pregnancy; Rats; Rats, Sprague-Dawley | 1994 |
D1 dopamine receptors mediate neuroleptic-induced Fos expression in the islands of Calleja.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adamantane; Animals; Antiparkinson Agents; Antipsychotic Agents; Benzazepines; Benzopyrans; Clozapine; Dopamine Agonists; Male; Olfactory Pathways; Proto-Oncogene Proteins c-fos; Raclopride; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Salicylamides | 1998 |